STOCK TITAN

Henry Schein (HSIC) Stock News

HSIC Nasdaq

Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.

Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.

Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.

Rhea-AI Summary

Henry Schein was awarded a $53.4 million contract by the U.S. Department of Health and Human Services for the storage and distribution of 80,000 pallets of personal protective equipment (PPE) and COVID-19 products to enhance the Strategic National Stockpile (SNS). This initiative supports ASPR's goal to optimize public health responses to emergencies. The company has a proven track record in providing essential medical supplies during the pandemic and emphasizes the importance of adequate emergency medical stock at care points.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
none
-
Rhea-AI Summary

Henry Schein One has acquired an 80% stake in Jarvis Analytics, a company developing data analytics tools for dental practices. This partnership aims to enhance decision-making and business performance for dental teams by utilizing data from various management systems. The financial impact from Jarvis Analytics is expected to be neutral to Henry Schein's earnings in 2021 but accretive thereafter. Stanley M. Bergman commented on the commitment to tech advancements, while Jarvis Analytics remains agnostic to practice management systems, expanding integration with Henry Schein's offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.71%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
none
Rhea-AI Summary

Henry Schein, the largest health care solutions provider for dental and medical practitioners, will present at four investor conferences in June 2021. The schedule includes:

  • Stifel 2021 Annual Dental & Veterinary Conference on June 2 at 2:00 p.m. ET.
  • Jefferies 2021 Virtual Healthcare Conference on June 3 at 2:00 p.m. ET.
  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 at 1:20 p.m. ET.
  • Baird Healthcare ESG Symposium on June 17 at 1:20 p.m. ET.

Live webcasts for the first three conferences are available on their website, with replays following the presentations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
conferences
-
Rhea-AI Summary

Henry Schein, Inc. (Nasdaq: HSIC) has elected Reed V. Tuckson, M.D., FACP, to its Board of Directors. Dr. Tuckson brings over 35 years of healthcare leadership, having previously served as Executive Vice President at UnitedHealth Group. He is known for his work with the Black Coalition Against COVID-19 and several advisory committees. Stanley M. Bergman, CEO, expressed confidence in Dr. Tuckson's ability to drive health equity and innovation. With this addition, HSIC aims to enhance its commitment to a socially responsible future and address disparities in health access.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
management
-
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC) has authorized a share repurchase program worth $400 million, complementing the remaining $33 million from a previous buyback initiated in October 2019. This new program represents approximately 4.0 percent of its 140 million outstanding shares. Executive VP Steven Paladino emphasized that this decision demonstrates the company's commitment to strategic priorities and solid cash flow generation, allowing for a balanced capital allocation strategy that supports growth and acquisitions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
buybacks
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none
-
Rhea-AI Summary

Henry Schein One has launched a new software module named Consistency of Care designed to integrate dental and medical patient records. This initiative responds to the increased demand from health care providers for comprehensive patient services. Developed by Exan Software, the module enhances interoperability, allowing dental schools to share patient records with medical schools. Penn Dental Medicine is the first to adopt this module. The integration aims to improve patient care, ensure accurate health records, and streamline data management, thereby enhancing overall patient outcomes and efficiency.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
none
-
Rhea-AI Summary

Henry Schein reported record Q1 financial results with total net sales of $2.9 billion, a 20.4% increase year-over-year. This surge was driven by 14.9% internal growth in local currencies, alongside contributions from acquisitions and foreign currency exchange. GAAP net income rose to $166 million ($1.16 per diluted share), up from $130.5 million ($0.91 per diluted share) in Q1 2020. The company also raised its 2021 non-GAAP EPS guidance to at least $3.70. Despite challenges from the pandemic, Henry Schein's performance reflects strong operational execution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.92%
Tags
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC), a leading health care solutions provider, will present at the Bank of America Securities 2021 Virtual Health Care Conference on May 11, 2021, at 10:15 a.m. ET. The presentation will be accessible via live webcast on the company's website, with a replay available afterward. Henry Schein serves over 1 million customers globally, offering more than 300 solutions that enhance operational efficiency and clinical outcomes for dental and medical practitioners. In 2020, the company reported sales of $10.1 billion, demonstrating significant growth since its public debut in 1995.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
conferences

FAQ

What is the current stock price of Henry Schein (HSIC)?

The current stock price of Henry Schein (HSIC) is $88.5 as of August 22, 2026.

What is the market cap of Henry Schein (HSIC)?

The market cap of Henry Schein (HSIC) is approximately 9.9B.